Concepedia

Shary Yuting Chen

SY

Statistics

Publications

4

Citations

239

H-Index

4

Active since

2017

Affiliations

University of British Columbia(Current)

BC Cancer Agency

Translational Genomics Research Institute

Canada's Michael Smith Genome Sciences Centre

University of North Carolina at Chapel Hill

Shary Yuting Chen is an author at University of British Columbia specializing in neoplasia, oncology, and histone methyltransferase inhibition.

Publications per year

2017–2023

4

Publications

4

The histone methyltransferase <scp>EZH2</scp> is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type

Yemin Wang, Shary Yuting Chen, Anthony N. Karnezis et al. · The Journal of Pathology · 2017 · 106 citations · Full text

Life Sciences, Genetics, Oncology +17

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Yemin Wang, Shary Yuting Chen, Shane Colborne et al. · Molecular Cancer Therapeutics · 2018 · 76 citations · Full text

Veterinary Medicine, Oncology, Carcinogenesis +11

Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines

Anthony N. Karnezis, Shary Yuting Chen, Christine Chow et al. · Gynecologic Oncology · 2020 · 46 citations · Full text

Medicine, Oncology, Pathology +14

Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer

Yemin Wang, Shary Yuting Chen, Monica Ta et al. · Cancer Research · 2023 · 11 citations

Life Sciences, Genetics, Molecular Genetics +14

1–4 of 4